RE:RE:RE:RE:RE:RE:RE:Redecan follow through or not???Touran77 wrote: VeritasVern wrote: Touran77 wrote:
Select55 wrote: as said redecan family currently down $138 million dollars will be intersting in the next two weeks to see if the deal goes forward or not
You don't like the deal anyway, so why do you care?
Based on bashers here on the forum, SP should go up a lot if they cancel right? :P
Let me help you with your confusion tiny tonto.
The Recan deal didn't offer much support so the price declined as much as other LPs. Redcan at least has some decent sales figures compared to the other two useless buyouts, but at a cost of $1 billion that is expensive. The market appears to be taking a wait and see approach. Redcan is the better deal of the three and if they bail then there could be a big sell-off and the Hexo sp declines quite a bit more. You seem like the only one with stop losses (and with a low price of $5.53 today they are likely triggered) but to all the long-strong holders they dont see the risk to the sp if in fact this is canceled. Good luck with the 'strategy" if that happens.
Verny, before the 30% miss in revenue, Hexo was doing a lot better than other LPs, you can easily verify with chart or just with logic (if doing same right now, but had a terrible earnings release, 1+1 equals that the market reacted well to the news prior to earnings).
You can also see that they were doing a lot better than other LPs only with the Zena news as well. Again anyone can check with chart. They also received lots of upgrade in SP targets right after the news of Zena acquisition. I can post the link if you want.
All that said, even if me and many analysts liked the zena acquisition, you have the right not to like it.
For Redecan, when I look at Tilray and Canopy which are worth 10B ish and Redecan having 5 times less revenues, my logic (simple math again) tell me that paying 1B was a great deal. Especially that Redecan has a technology that no one has and that a lot of customers are looking for. Again, you have the right not to like it.
All that said, just posted all the % down since high of feb from major LPs. Hexo is second right after the great VFF and they had the worst last earnings % wise (30% less in sales), how would you explain that if it is not the fact that market liked the zena/48N/Redecan news plus the news of expansion in USA? Again I am all hears if you have other ideas why.
Tonto
Average increase in gross sales was 17.9 % QTR over QTR for the trailing 3 QTRs. Last one was a dud, flop, disappointment, call it what you will. The company noted the corrective action in place so we wait and see how well those actions will reflect on the next QTR report and exactly how much (more or less) of the incremental 16 million from Zenabis shows up on that report